NeuroPace (NPCE) Misses Q2 EPS by 7c

NeuroPace (NASDAQ: NPCE) reported Q2 EPS of ($0.52), $0.07 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $11.08 million.

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15